China Pharma Holdings CPHI Q3 2011 Earnings EPS Miss Weighs on Sentiment IMMR Q3 2025 Earnings EPS Surges Past Estimates by Nearly 19 ADIL Q1 2026 Earnings Narrowed Loss Beats Estimates but Market Remains Cautious ProAssurance Q1 2026 Earnings EPS Misses Estimates Amidst Underwriting Headwinds MRAM Q1 2026 Earnings EPS Beats Estimates by 19 Stock Edges Higher HAE Q1 2026 Earnings EPS Slightly Beats Estimates Shares Edge Higher